KIF3A rs6543132: Understanding Its Role in Skin and Respiratory Health
The rs6543132 variant is a genetic change located within the KIF3A gene, which plays a role in cellular signaling and skin barrier maintenance. Research suggests this variant is associated with an increased risk of developing atopic dermatitis and asthma, particularly in individuals with both conditions.
What each genotype means
Typical skin barrier function
You carry two copies of the common C allele at rs6543132. Research indicates this genotype is associated with normal baseline KIF3A gene expression and typical skin barrier integrity. You do not carry the regulatory T allele linked to increased transepidermal water loss or elevated susceptibility to atopic dermatitis.
Carried by approximately 50% to 55% of individuals of European ancestry and is the predominant genotype across global populations.
Modestly increased eczema risk
You carry one copy of the T risk allele at rs6543132. Published functional studies associate this variant with increased DNA methylation and reduced KIF3A expression in epithelial tissue, which may moderately increase transepidermal water loss. In population research, having one copy is associated with a modestly elevated risk of developing atopic dermatitis and subsequent allergic airway conditions, though evidence remains limited and environmental factors play a substantial role.
Carried by roughly 35% to 40% of people of European ancestry, with lower prevalence observed in East Asian populations.
Elevated eczema and asthma susceptibility
You carry two copies of the T risk allele at rs6543132. Studies suggest this genotype confers the strongest reduction in KIF3A transcription due to altered regulatory methylation, predisposing to greater skin barrier dysfunction and water loss. Population studies link this profile to higher relative odds of developing atopic dermatitis and related allergic conditions, although overall clinical evidence for routine screening remains limited.
Carried by approximately 7% to 9% of individuals of European ancestry, and is relatively uncommon in most non-European cohorts.
What is rs6543132?
The rs6543132 variant is a single nucleotide polymorphism (SNP) located on chromosome 5q31.1 within the KIF3A gene. In genetics, a SNP represents a variation at a single position in the DNA sequence among individuals. This specific variant is categorized as a regulatory variant, meaning it does not necessarily change the structure of the protein produced by the gene, but rather influences how much of that protein is made. By altering the regulatory landscape of the KIF3A gene, this variant can impact the expression levels of the KIF3A protein in various tissues, including the skin and the lining of the nasal passages. Because it sits in a non-coding region, it is often studied for its role in modulating gene activity rather than altering the protein's primary function.
The Role of the KIF3A Gene
The KIF3A gene provides instructions for making a protein that is a key component of kinesin-2, a motor protein complex. This complex is essential for intracellular transport, moving molecules and organelles within cells. Beyond transport, KIF3A is critical for the formation and function of primary cilia, which act as sensory antennae for cells, allowing them to receive and process signals from their environment. In the context of the skin, KIF3A is vital for maintaining the skin barrier, which protects the body from external irritants and prevents excessive water loss. When KIF3A expression is reduced, the skin barrier may become dysfunctional, leading to increased dryness and susceptibility to inflammation, which are hallmarks of conditions like atopic dermatitis.
Research and Associations
Scientific research has identified associations between KIF3A variants and the 'atopic march,' a progression where eczema (atopic dermatitis) often precedes the development of asthma. Studies have shown that certain KIF3A SNPs can lead to increased methylation, a process that effectively turns down the production of the KIF3A protein. Lower levels of this protein have been linked to impaired skin barrier function and a higher likelihood of developing atopic dermatitis. While the evidence linking rs6543132 to these conditions is present, it is currently considered limited in strength. Many genetic studies emphasize that these associations are complex and often involve interactions between multiple genes and environmental factors. It is important to note that having this variant does not guarantee the development of any condition, as genetics is only one piece of a much larger health puzzle.
Population Frequency
The rs6543132 variant is relatively common in certain populations. According to data from gnomAD, the minor allele frequency (MAF) is approximately 0.28 in individuals of European ancestry. This means that a significant portion of the population carries at least one copy of the variant allele.
What This Information Means for You
Understanding your genetic profile regarding rs6543132 can provide insight into your biological predispositions, but it should not be used to diagnose or predict health outcomes. Because the evidence linking this specific SNP to disease is limited and the conditions it is associated with are multifactorial, this information is best viewed as a small part of your overall health profile. You cannot change your genetic code, but knowing about potential predispositions can encourage proactive discussions with your healthcare provider regarding skin care or respiratory health. If you have concerns about symptoms of atopic dermatitis or asthma, consult a dermatologist or an allergist. Never use genetic information to make decisions about medications or treatments without first discussing them with a qualified clinician or pharmacist who can provide personalized medical advice.
How common is this variant?
The rs6543132 variant is common, with a minor allele frequency of approximately 0.28 in European populations according to gnomAD data.
Frequently asked questions
Is rs6543132 a cause of asthma?
No, rs6543132 is not a direct cause of asthma. It is a genetic variant associated with a higher statistical risk, but asthma is a complex condition influenced by many genes and environmental factors.
Can I get tested for rs6543132?
While some direct-to-consumer genetic tests may include this SNP, it is not a standard clinical diagnostic test. Genetic testing for common traits is generally for informational purposes rather than medical diagnosis.
Does this variant mean I will definitely get eczema?
No. Having this variant does not mean you will develop eczema. Many people with this variant never develop skin conditions, and many people with eczema do not carry this specific variant.
What should I do if I have the risk genotype?
If you are concerned about your skin or respiratory health, focus on managing symptoms and environmental triggers. Discuss any specific health concerns with a doctor rather than focusing on a single genetic result.
Sources & further reading
Educational information only, last refreshed 10/11/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs6543132?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in KIF3A
Intronic regulatory SNP in KIF3A mediating skin barrier dysfunction and promoting progression along the atopic march to food allergy.
A functional SNP in the KIF3A gene that regulates gene transcription and is linked to impaired skin hydration and increased susceptibility to eczema.